|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07H 21/04 | (2006.01) |
| C12N 15/09 | (2006.01) |
| (11) | Number of the document | 3590949 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19177059.3 |
| Date of filing the European patent application | 2011-10-03 | |
| (97) | Date of publication of the European application | 2020-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-18 |
| (46) | Date of publication of the claims translation | 2022-07-25 |
| (30) | Number | Date | Country code |
| 40441310 P | 2010-10-01 | US |
| (72) |
SCHRUM, Jason P , US
SIDDIQI, Suhaib , US
EJEBE, Kenechi , US
|
| (73) |
ModernaTX, Inc. ,
325 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ribonukleorūgštys, kurių sudėtyje yra N1-metil-pseudouracilų, ir jų naudojimas |
| RIBONUCLEIC ACIDS CONTAINING N1-METHYL-PSEUDOURACILS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-09-26 | 15 | 289.00 EUR |
| 2026-10-03 |